Masoumeh Safdari-Molan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Masoumeh Safdari-Molan has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
Esmat Mehrabi
Midwifery Department, Nursing and Midwifery Faculty, Tabriz University of Medical Sciences, Tabriz, Iran
1 shared publicationReza Eghdam-Zamiri
Medical School, Tabriz University of Medical Sciences, Tabriz, Iran
1 shared publication- Roghaiyeh Nourizadeh
Integrative Medicine in Aging, Aging Research Institute, Clinical Research Development Unit of Taleghani Hospital, Tabriz University of Medical Sciences, Tabriz, Iran
1 shared publication
Latest Publications
- Open Access
- 25 March 2023
- Published by Springer Nature in BMC Women's Health
- Vol. 23 (1) , 1-7
Predictors of the worry about cancer recurrence among women with breast cancer
Introduction: Worry about cancer recurrence is identified as the most common psychological burdens experienced by cancer patients and survivors. The present study aimed to determine the predictors of worry about cancer recurrence among women with breast cancer.Materials and methods: This cross-sectional study was conducted on 166 women with breast cancer undergoing chemotherapy and radiotherapy, who referred to private and public oncology centers in Tabriz, Iran using the convenience sampling. Data collection tools were demographic and disease characteristics questionnaire, cancer worry scale, social support questionnaire, brief illness perception questionnaire, international physical activity questionnaire-short form, and The EORTC-in-patsat32. The data were analyzed using SPSS 25 software. Pearson correlation coefficient, independent t-test, ANOVA, and multivariate linear regression were used.Results: In the present study, the mean (standard deviation) of score of worry about cancer recurrence was 17.41 (7.88), ranging from 8–32. The results revealed that the type of surgery, illness perception, satisfaction with care, and place of treatment were the most important predictors of worry about cancer recurrence, which explained 44.3% of the variance.Conclusion: The enhancement of satisfaction with care and training coping strategies among individuals with high perceived severity of the illness contribute to the reduction of worry about cancer recurrence and adaptation to breast cancer.
- 25 March 2023
- Published by Springer Nature in BMC Women's Health
- Vol. 23 (1) , 1-7
Open AccessPredictors of the worry about cancer recurrence among women with breast cancer
Introduction: Worry about cancer recurrence is identified as the most common psychological burdens experienced by cancer patients and survivors. The present study aimed to determine the predictors of worry about cancer recurrence among women with breast cancer.Materials and methods: This cross-sectional study was conducted on 166 women with breast cancer undergoing chemotherapy and radiotherapy, who referred to private and public oncology centers in Tabriz, Iran using the convenience sampling. Data collection tools were demographic and disease characteristics questionnaire, cancer worry scale, social support questionnaire, brief illness perception questionnaire, international physical activity questionnaire-short form, and The EORTC-in-patsat32. The data were analyzed using SPSS 25 software. Pearson correlation coefficient, independent t-test, ANOVA, and multivariate linear regression were used.Results: In the present study, the mean (standard deviation) of score of worry about cancer recurrence was 17.41 (7.88), ranging from 8–32. The results revealed that the type of surgery, illness perception, satisfaction with care, and place of treatment were the most important predictors of worry about cancer recurrence, which explained 44.3% of the variance.Conclusion: The enhancement of satisfaction with care and training coping strategies among individuals with high perceived severity of the illness contribute to the reduction of worry about cancer recurrence and adaptation to breast cancer.